347 related articles for article (PubMed ID: 9684847)
1. New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease.
Gould KL
Am J Med; 1998 Jun; 104(6A):2S-17S. PubMed ID: 9684847
[TBL] [Abstract][Full Text] [Related]
2. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
3. Coronary arteriography and lipid lowering: limitations, new concepts, and new paradigms in cardiovascular medicine.
Gould KL
Am J Cardiol; 1998 Sep; 82(6A):12M-21M. PubMed ID: 9766343
[TBL] [Abstract][Full Text] [Related]
4. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.
Gould KL; Martucci JP; Goldberg DI; Hess MJ; Edens RP; Latifi R; Dudrick SJ
Circulation; 1994 Apr; 89(4):1530-8. PubMed ID: 8149518
[TBL] [Abstract][Full Text] [Related]
5. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
Sdringola S; Nakagawa K; Nakagawa Y; Yusuf SW; Boccalandro F; Mullani N; Haynie M; Hess MJ; Gould KL
J Am Coll Cardiol; 2003 Jan; 41(2):263-72. PubMed ID: 12535820
[TBL] [Abstract][Full Text] [Related]
6. Medical management of coronary artery disease revisited: the endothelial factor.
Siegel JA
J S C Med Assoc; 1997 Sep; 93(9):333-5. PubMed ID: 9316336
[TBL] [Abstract][Full Text] [Related]
7. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Intracoronary Vascular Ultrasound Indexes in Patients with Coronary Heart Disease.
Zhang P; Wang R; Zhang A; Li F; Li X; Chen W; Li H; Li Z; Li F
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38290442
[TBL] [Abstract][Full Text] [Related]
9. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.
Mark DB; Nelson CL; Califf RM; Harrell FE; Lee KL; Jones RH; Fortin DF; Stack RS; Glower DD; Smith LR
Circulation; 1994 May; 89(5):2015-25. PubMed ID: 8181125
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of acute coronary syndromes and the potential role of statins.
Dupuis J
Atheroscler Suppl; 2001 Feb; 2(1):9-14. PubMed ID: 11286155
[TBL] [Abstract][Full Text] [Related]
11. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
Simoons ML; Windecker S
Eur Heart J; 2010 Mar; 31(5):530-41. PubMed ID: 20106842
[TBL] [Abstract][Full Text] [Related]
12. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
Wilson JM; Ferguson JJ
Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
[TBL] [Abstract][Full Text] [Related]
13. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy.
Hunninghake DB
Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501
[TBL] [Abstract][Full Text] [Related]
15. Lipid lowering versus revascularization: an idea whose time (for testing) has come.
Forrester JS; Shah PK
Circulation; 1997 Aug; 96(4):1360-2. PubMed ID: 9286970
[TBL] [Abstract][Full Text] [Related]
16. Imaging Microvascular Dysfunction and Mechanisms for Female-Male Differences in CAD.
Patel MB; Bui LP; Kirkeeide RL; Gould KL
JACC Cardiovasc Imaging; 2016 Apr; 9(4):465-82. PubMed ID: 27056165
[TBL] [Abstract][Full Text] [Related]
17. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
Morrison DA; Sacks J
Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
[TBL] [Abstract][Full Text] [Related]
18. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography.
Gould KL; Nakagawa Y; Nakagawa K; Sdringola S; Hess MJ; Haynie M; Parker N; Mullani N; Kirkeeide R
Circulation; 2000 Apr; 101(16):1931-9. PubMed ID: 10779459
[TBL] [Abstract][Full Text] [Related]
19. Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.
Lang IM; Badr-Eslam R; Greenlaw N; Young R; Steg PG
Wien Klin Wochenschr; 2017 Dec; 129(23-24):879-892. PubMed ID: 28913755
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography and the changing paradigm in coronary artery disease.
Schelbert HR
Z Kardiol; 2000; 89 Suppl 4():IV55-60. PubMed ID: 10810777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
